Page last updated: 2024-11-02

pioglitazone and African Lymphoma

pioglitazone has been researched along with African Lymphoma in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zang, C1
Liu, H1
Posch, MG1
Waechter, M1
Facklam, M1
Fenner, MH1
Ruthardt, M1
Possinger, K1
Phillip Koeffler, H1
Elstner, E1

Other Studies

1 other study available for pioglitazone and African Lymphoma

ArticleYear
Peroxisome proliferator-activated receptor gamma ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia.
    Leukemia research, 2004, Volume: 28, Issue:4

    Topics: Adolescent; Apoptosis; Blotting, Western; Burkitt Lymphoma; Cell Cycle; Cell Division; Cell Line, Tu

2004